Correlation Between Level Biotechnology and Genovate Biotechnology

Can any of the company-specific risk be diversified away by investing in both Level Biotechnology and Genovate Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Level Biotechnology and Genovate Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Level Biotechnology and Genovate Biotechnology Co, you can compare the effects of market volatilities on Level Biotechnology and Genovate Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Level Biotechnology with a short position of Genovate Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Level Biotechnology and Genovate Biotechnology.

Diversification Opportunities for Level Biotechnology and Genovate Biotechnology

0.36

Correlation Coefficient

Level Biotechnology  Genovate Biotechnology

Weak diversification

The 3 months correlation between Level and Genovate is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Level Biotechnology and Genovate Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genovate Biotechnology and Level Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Level Biotechnology are associated (or correlated) with Genovate Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genovate Biotechnology has no effect on the direction of Level Biotechnology i.e., Level Biotechnology and Genovate Biotechnology go up and down completely randomly.

Pair Corralation between Level Biotechnology and Genovate Biotechnology

Assuming the 90 days trading horizon Level Biotechnology is expected to generate 25.18 times less return on investment than Genovate Biotechnology. But when comparing it to its historical volatility, Level Biotechnology is 3.29 times less risky than Genovate Biotechnology. It trades about 0.01 of its potential returns per unit of risk. Genovate Biotechnology Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  2,245  in Genovate Biotechnology Co on October 22, 2024 and sell it today you would earn a total of  125.00  from holding Genovate Biotechnology Co or generate 5.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Level Biotechnology  vs.  Genovate Biotechnology Co

Level Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Level Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Level Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Genovate Biotechnology

Risk-Adjusted Performance

4 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Genovate Biotechnology Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Genovate Biotechnology may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Level Biotechnology and Genovate Biotechnology

The main advantage of trading using opposite Level Biotechnology and Genovate Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Level Biotechnology position performs unexpectedly, Genovate Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genovate Biotechnology will offset losses from the drop in Genovate Biotechnology's long position.

The idea behind Level Biotechnology and Genovate Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.